• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BIND Therapeutics Inc

+ Add to Watchlist

BIND:US

9.2500 USD 0.0200 0.22%

As of 17:20:00 ET on 07/25/2014.

Snapshot for BIND Therapeutics Inc (BIND)

Open: 9.2500 Day's Range: 9.0500 - 9.5399 Volume: 84,882
Previous Close: 9.2300 52wk Range: 8.0000 - 15.8900 1-Yr Rtn: -

Stock Chart for BIND

No chart data available.
  • BIND:US 9.2400
  • 1D
  • 1M
  • 1Y
9.2300
Interactive BIND Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIND

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.0600
Est. PEG Ratio -
Market Cap (M USD) 151.83
Shares Outstanding (M) 16.45
30 Day Average Volume 168,892
Price/Book (mrq) 2.1900
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIND

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIND

BIND Therapeutics Inc researches and produces biopharmaceutical products. The Company develops selective targeted and programmable therapeutics to maximize active pharmaceutical ingredients concentrations in diseased tissues. BIND Biosciences serves patients worldwide.

Scott MinickPresident/CEOAndrew J HirschCFO/COO
Jeff HrkachChief Technology OfficerEdward F Schnipper "Ed"Interim Chief Medical Officer
More Company Profile & Key Executives for BIND

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil